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Abstract 
Over the past several years, pediatric allergies have come to the forefront of many 
studies.  Reports of immune-mediated hypersensitivity in younger patients have grown 
and led to an interest researching the causes of pediatric hypersensitivities.  There are 
various risk factors that have been discussed that may lead to the development of 
allergies including genetic inheritance, genetic mutation, and environmental sensitization.  
It is important for all of these factors to be discussed in relation to the function of the 
immune system and its role in hypersensitivity reactions.  If the causes of hypersensitivity 
reactions could be further studied and understood, treatments might be developed to 
reduce or eliminate these hypersensitivity reactions in younger pediatric populations.  
Much research has been done regarding the risk factors for pediatric hypersensitivity 
reactions and many recommendations have been made to combat this growing 
phenomenon.  It is important to review the mechanisms of hypersensitivity reactions, the 
risk factors for developing them, and to research the incidences of pediatric 
hypersensitivity reactions and the recommended interventions for future diagnosis and 
treatment of hypersensitivity reactions in the pediatric population. 
Keywords: Immune-mediated hypersensitivity reactions, pediatrics  
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Introduction 
 The mechanism behind hypersensitivity reactions lie in the immune system.  The 
immune system is a fascinating and complicated organization of cells and organs that are 
designed to protect the body from foreign invading organisms that are potentially harmful 
(McKinley, O’Loughlin, & Bidle, 2016).  Hypersensitivity reactions occur when the 
immune system overreacts to foreign organisms that present with specific antigens.  This 
can cause a wide variety of negative effects from urticaria to angioedema and 
anaphylaxis.  This occurs through a complex pathway mediated by the immunoglobulin E 
(IgE).  When mast cells with the IgE surface antigen encounter an allergen or the 
triggering antigen, histamine is released from the mast cell causing a widespread reaction 
in the body.  The smaller pathways that occur within this immunological response 
pathway are complex and intricate, and variations in these pathways can alter the type of 
allergic response displayed (Borzova & Grattan, 2013, pp. 506-521).  It is important to 
study the details of these pathways so that a proper understanding might be reached and 
appropriate diagnosis and treatment recommendations might be made.  Early diagnosis of 
allergic reaction is necessary because allergic reactions are so prevalent.  A study done in 
2006 revealed that 7.7% of children were diagnosed with a food hypersensitivity by the 
time they were three years old (Carina, Brett, Grundy, Clayton, & Roberts, 2006).  Since 
that time, the incidence of allergies has only risen (Hockenberry, Wilson, & Rodgers, 
2017).  Hypersensitivity to food is not the only issue.  Hypersensitivity reactions to drugs 
have also been noted to be on the rise, and identifying the allergies and treating them is 
imperative, especially in the healthcare setting (Ariza, Fernandez, Mayorga, Blanca, & 
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Torres, 2013).  Because so much research is being done in the field, it is essential for 
those looking to work in pediatrics to understand the pathophysiology behind 
hypersensitivity reactions and the rationales behind current diagnostics and treatments. 
 The current literature is pointing to several factors leading to the development of 
hypersensitivity reactions in pediatric patients.  Pediatric patients for this paper will be 
defined from birth to 21 years old.  The foremost factor being researched is the role of 
genetics in the development of allergies.  Alterations in the genetic code can lead to 
alterations in the immune response pathways thus leading to overreactions to specific 
antigens.  For instance, a recent study revealed that allergies to beta-lactam antibiotics are 
often related to alterations in the interleukin (IL) 4, IL-3, and the IL-4 receptor-alpha-
chain within the IgE-mediated pathway (Ariza, Fernandez, Mayorg, Blanca, & Torres, 
2013).  Ariza et al. (2013) also reported that previous studies had found a relationship 
between the differences in the HLA-B 1502 and the HLA-B 5801 alleles and the risk of 
developing hypersensitivity reactions to anti-epileptic drugs.  The research seems to be 
pointing to the fact that genetics do in fact play a role in determining hypersensitivity 
reactions.  Because of the prevalence of allergies, much of the literature has focused on 
diagnosis, prevention, and treatment.  Newer research and studies are now beginning to 
change recommendations as they are finding out that older recommendations are 
unsuccessful.  In the Longo et al. study (2013), restricting maternal diet during 
breastfeeding and then restricting the child’s diet from allergenic foods failed to reduce 
the prevalence of hypersensitivity reactions, but rather led to an increase in these 
hypersensitivity reactions (Longo, Berti, Burks, Krauss, & Barbi, 2013).  In recent years, 
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due to recommendations from healthcare providers and researchers, more studies have 
been done to research the risk factors for development, the genetic impact on 
hypersensitivity reactions, strategies for prevention, the necessity of early diagnosis, and 
the different types of treatment.   
 It is important to understand the basic function and workings of the immune 
system so that the precise pathways by which hypersensitivity reactions occur might be 
comprehended.  Understanding the IgE mediated pathways is essential for covering 
pediatric hypersensitivity reactions.  This is essential because many of the genetic 
variations that have been studied with regards to hypersensitivity reactions are variations 
within the IgE pathway.  It is important to understand how these function in the pediatric 
population, especially in infants.  In the past, few studies have been done on these 
populations, but within recent years more research has been done.  Recent studies have 
also shown that previous plans of prevention and treatment have not been as successful as 
hoped, and therefore further recommendations for prevention, diagnosis, treatment, and 
further research has been made.  It is essential for pediatric healthcare providers to 
understand all of these factors and to be able to implement them in practice so that the 
best care can be provided to the pediatric population. 
The Role of the Immune System in Hypersensitivity 
 Hypersensitivity reactions occur when the immune system identifies a particular 
protein as foreign to self and a potential danger.  In food hypersensitivities, this happens 
when the immune cells within in the digestive tract identify a specific food protein as 
dangerous (Grosvenor and Smolin, 2015).  According to the Gell and Coombs 
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Classification of allergic responses, allergic responses occur in four major ways.  Type I 
allergic responses are governed through the IgE pathway.  Type II is cytotoxic (Ariza, 
Fernandez, Mayorg, Blanca, & Torres, 2013).  Cytotoxic reactions are mediated by IgG 
and IgM.  This results in phagocytosis of the antigen and cellular injury (Moriber, 2014, 
pp. 329-360).  Type III is the immunocomplex reaction (Ariza, Fernandez, Mayorg, 
Blanca, & Torres, 2013).  Immunocomplex reactions are produced through the 
combinations of antigen-antibody immune complexes that form within the bloodstream.  
When these complexes embed themselves in the endothelium of the vasculature, systemic 
inflammatory response ensues (Moriber, 2014, pp. 329-360).  Type IV is delayed type 
hypersensitivity (Ariza, Fernandez, Mayorg, Blanca, & Torres, 2013).  Delayed type 
hypersensitivity is cell mediated and therefore is not immediate (Moriber, 2014, pp. 329-
360).   
The IgE-Mediated Pathway 
Most immune responses to food allergens resulting in hypersensitivity are 
governed through the IgE-mediated pathway.  There are several important cells within 
the immune system.  B-cells are responsible for removing toxins and extracellular 
microbes and for developing memory to defend against future infections.  B-cells also 
produce antibodies, which are also known as immunoglobulins.  There are five different 
types of immunoglobulins: IgG, IgA, IgM, IgD, and IgE.  Each of the immunoglobulins 
are responsible for producing a specific immune response.  IgE is responsible for 
inflammation, allergic response, and fighting parasitic infections (Moriber, 2014, pp. 
276-305).  IgE production is promoted by interleukins, specifically IL-4 and IL-13 
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(Eisenstein, Sullivan, & Williams, 2011, pp. 769-754).  Interleukins are types of 
cytokines.  Cytokines are polypeptides that are produced by various cells that stimulate 
the function of immune and non-immune responses within the body (O’Shea, Gadina, & 
Siegel, 2013, pp. 108-135).  IL-4 and IL-13 are produced by TH2 cells.  TH2 cells are a 
specific type of CD4+ T helper cells.  TH2 cells are essential for the acute 
hypersensitivity pathway as well as promoting the chronic and relapsing presentation of 
eosinophil chronic allergic inflammation (Eisenstein, Sullivan, & Williams, 2011, pp. 
769-754).  Normally, TH2 cells are inhibited by TH1 and Treg cells.  TH1 and Treg cells 
are also CD4+ T helper cells.  In IgE-mediated disorders, TH2 is inadequately regulated 
by TH1 and Treg cells and thereby the hypersensitivity reaction occurs.  When IgE binds 
with an allergen and then comes in contact with the FcεRI high affinity receptor on mast 
cells and basophils, the mast cells and basophils release histamine which is the primary 
cause of immediate allergic symptoms (Bohle, 2013, pp. 543-549). 
Anaphylaxis 
 Histamine is a vasoactive amine that causes increased capillary permeability, 
vasodilation, and bronchoconstriction (Delany, Baker, Bastardi, & O’Brien, 2017, pp. 
738-785).  The increased capillary permeability causes fluid leakage into the interstitial 
space leading to interstitial edema and decreased vascular volume.  This massive 
systemic response is called anaphylaxis and must be treated rapidly to avoid deterioration 
into anaphylactic shock.  The interstitial edema leads to laryngeal edema.  Laryngeal 
edema combined with bronchoconstriction leads to respiratory distress.  Rapid 
vasodilation leads to circulatory collapse that can lead to circulatory failure.  Symptoms 
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include chest pain, dizziness, incontinence, pruritus, flushing, angioedema, urticaria, 
anxiety, wheezing, stridor, and swelling of the lips and tongue.  These symptoms are 
generally the same regardless of the age of the patient (Seckel, 2017, pp. 1587-1608). 
Class 1 and Class 2 Food Allergies 
There are two types of food allergies mediated by IgE.  Class 1, also known as 
primary, is a true food allergy that often arises in early childhood or infancy.  This 
reaction results from the interaction of food proteins and the immune cells within the 
digestive track.  This results in a variety of symptoms from symptoms specific to the 
gastrointestinal track to anaphylaxis and urticaria.   Class 2, also known as secondary, 
describes the reactions that result from cross-sensitivity to respiratory allergens.  This 
type of reaction mostly occurs in the adolescent and adult population, and thus will not be 
discussed.  Allergens that cause primary reactions pass through the stomach without 
being broken down by pepsin and hydrochloric acid.  Once in the intestines, the food 
proteins come in contact with the gut-associated lymphoid tissue (GALT).  GALT is 
responsible for distinguishing between normal GI flora, harmless food proteins, and 
pathogens.  M cells are responsible for transporting the antigens and presenting them to 
the lymphoid tissue for discrimination.  Some antigens come in direct contact with 
dendritic cells without being transported by M cells.  Some antigens cross into the 
lymphoid tissue without any transportation assistance.  Once the antigen presenting cell 
(APC) comes in contact with the antigen, it brings it to the appropriate T-cell for 
determination.  Any disorder involving the determination of the particular T-cells can 
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lead to an immediate immune response leading to hypersensitivity reactions (Bohle, 
2013, pp.  543-549). 
When the T-cells appropriately recognize food proteins as harmless the inhibition 
of further immune response is called oral tolerance.  There are several theories regarding 
the development of oral tolerance or lack thereof relating to genetic factors, gut epithelial 
barrier integrity, and the degree of concurrent local immune activation.  Primary food 
allergy occurs when oral tolerance fails to develop and a hypersensitivity reaction occurs.  
Because there are so many factors within the pathway through which food proteins are 
presented to the T-cells within the GALT, it is very difficult to determine exactly why 
food allergies develop.  Oral tolerance can only develop when immune homeostasis has 
been achieved.  Immune homeostasis can only develop during specific windows of 
opportunity during the coordination of innate and adaptive immunity through APC 
orchestration with microbial products and dietary constituents (Bohle, 2013, pp.  543-
549). 
Genetic Risk Factors 
 There is some evidence that shows that the development of hypersensitivity 
reactions could be related to various genetic risk factors.  According to The Health 
Professional’s Guide to Food Allergies and Intolerances, children can inherit allergic 
reactions from their parents.  This inheritance, however, is not an inheritance of a specific 
allergy, but rather an inheritance of the potential to develop an allergy through the 
abnormal function of TH2 cells (Joneja, 2013).  Pregnant mothers pass on 
immunoglobulins to their babies through the placenta and through breastmilk (Davidson, 
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London, & Ladewig, 2016).  Most of the time, these immunoglobulins that are passed on 
are IgG1 and IgG3.  Mothers who already have a hypersensitivity reaction pass on IgE 
and IgG4.  IgG4 is not able to pass the placenta, and thus the baby developing in the 
womb receives a high concentration of IgE.  This may lead to an increased change of 
development of a hypersensitivity reaction (Joneja, 2013).   
Some children may also have a genetic predisposition to developing 
hypersensitivity reactions not through their parents, but rather through chromosomal 
anomalies.  In a 2013 study, several children were tested for IL-17 production from 
CD4+ T cells.  This test was conducted both in vivo and ex vivo.  In both scenarios, 
children who were later diagnosed with a food hypersensitivity reaction were found to 
have decreased levels of IL-17.  IL-17 is important for the repression of TH2 cytokines 
and the TH2-recruiting chemokine production (Dhuban, D’hennezel, Ben-shoshan, 
Mccusker, Clarke, et al. 2013).  As shown above, abnormal TH2 function leads to over-
reaction of the IgE-mediated pathway thus causing the systemic hypersensitivity 
response.  Thus, decreased production of IL-17 can predispose a patient to the 
development of a food allergy.   
There is currently much research being conducted on the relationship between 
different types of HLA (human leukocyte antigen) and the development of 
hypersensitivity reactions.  While not enough research has been done to link specific 
types of HLA with different allergens, it has been shown that all ethnic groups who have 
variations on the HLA-B*1502 and HLA-B*5801 alleles have an increased risk of 
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developing hypersensitivity reactions to antiepileptic drugs like carbamazepine or 
allopurinol (Ariza, Fernandez, Mayorg, Blanca, & Torres, 2013). 
Prevalence 
 The prevalence of hypersensitivity reactions can be difficult to identify because 
there is such a wide variety of types and timings of the reactions (Hernandez, Ponce, 
Busquets, Hernandez, & Oliva, 2016).  For instance, infants may present with atopic 
eczema, gastroesophageal reflux, or infantile colic (Ho, Wong, & Chang, 2012).  There is 
also a plethora of allergens that may induce a hypersensitivity reaction. In pediatric 
patients, the most common allergens are the result of egg, milk, wheat, soy, tree nuts, 
peanuts, fish, and shellfish.  Children will often outgrow their allergies to eggs and milk, 
however allergies to peanuts and tree nuts are not usually outgrown (Ho, Wong, & 
Chang, 2012). 
 There are many estimates regarding the percentage of infants and children who 
suffer from food hypersensitivity reactions.  According to a recent study, “In spite of 
many articles dealing with this issue, the true prevalence of allergic drug reactions is not 
well known, and the associated morbidity, mortality and economic cost are often 
underestimated” (Ariza, Fernandez, Mayorg, Blanca, & Torres, 2013).  A 2013 study 
estimated that approximately 3-8% of children are affected by food hypersensitivity 
reactions (Long, Berti, Burks, Krauss, & Barbi).  It has been noted that the number of 
children who are being diagnosed with food hypersensitivity reactions worldwide has 
been increasing in recent years (Ho, Wong, & Chang, 2012).  This has driven public 
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health official to label food hypersensitivity as an evolving public health issue (Long, 
Berti, Burks, Krauss, & Barbi. 2013).   
 Even though the effects of food hypersensitivity reactions are often 
underestimated, very often the reported number of food hypersensitivity reactions is 
lower than the actual number of food hypersensitivity reactions.  In a 2012 study, out of 
20-30% of parents who reported a food allergy in their child, only 6-8% of those children 
have been diagnosed with an actual food allergy (Ho, Wong, & Chang).  More education 
is needed about what a food allergy is, the symptoms associated with a true food allergy, 
and how to diagnose a food allergy. 
 
Recommendations for Prevention 
 For many years, the recommendation for the prevention of food allergies was for 
breastfeeding and pregnant mothers to avoid consuming foods like fish, eggs, and cow’s 
milk.  These foods are potentially allergenic, and it was thought that delayed exposure to 
these foods would allow the infant’s immune system enough time to develop so that 
sensitization would not develop.  However, in a 2012 Cochrane review, five trials found 
that avoidance of such food did not decrease the development of hypersensitivity 
reactions, but rather negatively impacted the nutritional health of both the mother and the 
baby.  It is, however, still possible for an infant to experience hypersensitivity reactions 
to food that the mother ingests while breastfeeding.  According the guide, Counseling the 
Lactating Mother, “An infant is rarely, if ever, allergic to the mother’s milk.  At the same 
time, the infant may show allergic symptoms in response to foods ingested by the mother 
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and passes through her milk.  Allergens pass through the mother’s milk and may cause 
reactions such as spitting, vomiting, gas, diarrhea, colicky behavior, or skin rash” 
(Lauwers, & Swisher, 2016, p. 199).  Further symptoms include angioedema, urticaria, 
pruritus, erythema, abdominal pain, vomiting, hoarse voice, persistent cough, stridor, 
wheeze, nasal congestion, or respiratory distress (Longo, Berti, Burks, Krauss, & Barbi, 
2013).   
Breastfeeding 
Counseling the Lactating Mother states, breastmilk is the best option for 
prevention of development of hypersensitivity reactions.  While breastfeeding does not 
fully prevent the development of all hypersensitivity reactions, the use of formula has 
been linked to an increase in the risk of development of hypersensitivity reactions.  This 
is because the infant’s intestinal tract has not yet fully matured and requires 
immunoglobulins from the mother for the infant’s immune system to appropriately 
function (Lauwers, & Swisher, 2016, p. 199).  While breastfeeding does seem to prevent 
the development of allergies, prolonged breastfeeding may promote the development of 
hypersensitivity reactions.  Recent studies have found that exclusive breastfeeding 
beyond four months no longer has a major effect on preventing food allergies.  Exclusive 
breastfeeding after 6 months has no impact on the development of hypersensitivity 
reactions (Longo, Berti, Burks, Krauss, & Barbi, 2013). The American Academy of 
Pediatrics has stated that exclusive breastfeeding for the first few months of life have 
been shown to be helpful in preventing the development of hypersensitivity reactions.  
“There is a protective effect of exclusive breastfeeding for 3-4 months in reducing the 
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incidence of clinical asthma, atopic dermatitis, and eczema by 27% in a low-risk 
population and up to 42% in infants with positive family history” (American Academy of 
Pediatrics, 2012). 
 
Food Avoidance  
Along with the advice to pregnant and breastfeeding mothers to avoid allergenic 
foods, it was recommended to avoid introducing the most allergenic foods during the first 
year of life and perhaps even later.  This was because it was believed that the later the 
allergenic food was introduced, the better.  The idea was to reduce the incidence of food 
hypersensitivity reactions later in life.  The result was the opposite of what was 
anticipated.  Newer research has instead indicated that introducing allergenic food earlier 
on in life may promote tolerance in the infant’s immune system and thus reduce the 
incidence of hypersensitivity reactions.  This should be done carefully, but the hope is 
that if this is introduced, fewer children may develop hypersensitivity reactions (Joneja, 
2013).   
A 2013 meta-analysis reviewed several earlier studies that tracked the 
introduction of allergenic foods into children’s diets and the incidence of food 
hypersensitivities.  The study found that Israeli children who had been given peanut 
butter beginning at six months of age were ten times less likely to develop a 
hypersensitivity reaction to peanuts than their United Kingdom Jewish counterparts who 
were not give peanut butter until they were older as suggested by public health 
campaigns.  Because the Israeli and Jewish children had the same genetics, the most 
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likely explanation is that the early introduction to the peanut allergy actually prevented 
sensitization and reduced the incidence of a peanut allergy (Longo, Berti, Burks, Krauss, 
& Barbi, 2013).  The same meta-analysis found that development of tolerance might be 
promoted by exposure to allergens during critical time windows in early development.  
These time windows are between three and four months of age and six and seven months 
of age.  Further research is still required to find the best route forward with regards to 
early feeding practices. (Longo et al., 2013). 
Recommendations for Diagnosis 
 The number of reported food hypersensitivity reactions is far greater than the 
actual number of real food hypersensitivity reactions.  Thus, it is imperative that 
healthcare providers know how to diagnose food allergies.  Health care professionals 
should be familiar with what constitutes a food hypersensitivity leading to an allergic 
reaction and what is simply a food intolerance.  According to an article entitled, 
Incidence of Parentally Reported and Clinically Diagnosed Food Hypersensitivity in the 
First Year of Life, “Food hypersensitivity can be divided into either food allergy if 
immunologically mediated or nonallergic food hypersensitivity, previously referred to as 
food intolerance.  The gold standard in establishing food hypersensitivity is the double-
blind, placebo-controlled food challenge (DBPCFC)” (Venter, et al., 2006).   
DBPCFC 
The DBPCFC is used to determine whether the food in question is causing the 
allergic reaction.  If the patient has an allergic reaction to the tested food, the patient is 
most likely allergic to that particular food protein, though additional testing might be 
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needed to develop a definitive diagnosis (Venter, et al., 2006).  The elimination and 
challenge procedure may also be used to determine specific foods or food products that 
are causing allergic reactions.  This involves eliminating the suspected foods from the 
diet and then slowly reintroducing the foods one at a time into the diet.  Selection of these 
suspected foods is based on a careful medical history, testing if appropriate, and food 
intake diaries.  If the foods cause a reaction, the food is withdrawn, and an appropriate 
dietary guideline is then drawn (Joneja, 2013). 
Skin Testing 
 Alternative testing involves skin testing.  Skin testing may take several forms, 
though all forms of testing have the same positive and negative results (Joneja, 2013).  
According to The Healthcare Professional’s Guide to Food Allergies and Intolerances, 
“[skin testing] is designed to reveal the IgE, which is fixed to the skin mast cell.  When 
the allergen bridges to IgE molecules on the surface of the cell, inflammatory mediators 
(particularly histamine) are released that cause edema (swelling) and erythema 
(reddening) – the “wheal and flare reaction”” (Joneja, 2013, p. 58).  The three methods of 
skin testing are the prick test, the scratch test, and the intradermal test.   
The prick test involves dropping an allergen onto the skin and then pricking the 
skin underneath the drop with a lancet.  The scratch test involves scratching the skin with 
a sterile instrument and then dropping the allergen onto the excoriated skin.  The 
intradermal test involves injecting the allergen directly into the skin using a syringe.  
With all of these tests, two controls must be used.  The first control is a specific amount 
of histamine.  The second control is the solution in which the allergen is place and is 
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called the negative control; this is normally saline.  The test is ruled invalid if the 
histamine fails to produce a wheal less than 3mm in diameter or if the negative control 
triggers a reaction.  A positive reading is defined as a wheal that is at least 3mm larger 
than the negative control.  If it is suspected that the patient has a delayed hypersensitivity 
reaction, a patch test may be used in which the allergen is introduced to the body through 
patch that remains on the skin for a set period of time.  If the physician wishes to test for 
specific food antibodies, a blood test may be used.  Blood tests must be only be used if 
accompanied by a physical examination and careful history (Joneja, 2013). 
Elimination Diets and Challenges 
 Elimination diets and challenges must be performed carefully so that an 
appropriate diagnosis may be made.  In order for a proper diagnosis to be made an 
elimination diet must be performed to remove the suspected foods that contain the 
allergens.  Once the symptoms have subsided, the foods may be introduced one at a time 
into the diet.  If the food causes a reaction, then a diagnosis of food allergy may be made 
(Joneja, 2013). 
 There are three basic kinds of elimination diets: Selective elimination diets, few 
food elimination diets, and elemental diets.  Selective elimination diets involve removing 
one or a few numbers of foods from the diet.  Few foods elimination diets involve 
avoiding all foods except for a select number for a specified time period.  Elemental diets 
eliminate all solid foods and allow only an amino acid-based formula.  This may 
occasionally involve considerably hydrolyzed formula, especially for children and 
infants.  The specific elimination diet to be used must be carefully chosen.  The decision- 
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making process is governed by results of previous allergy testing, a 7-day food exposure 
diary, a detailed medical history, identification and exclusion of any other possible causes 
of symptoms (Joneja, 2013).  
Selective elimination diets. 
Selective elimination diets are best used when it is believed that a specific food 
ingested is causing a specific reaction. Normally, the specific foods are avoided for four 
weeks.  This time frame was chosen because it allows enough time for the patient to be 
free of the symptoms that the food is potentially causing.  This also allows enough time 
to appropriately challenge the allergen.  Even though the symptoms might be eliminated, 
the circulating levels of IgE remain unchanged, and thus when the food is reintroduced, a 
reaction will be provoked, thus confirming the diagnosis.  Selective elimination diets may 
also show that a specific food is not responsible for the symptoms.  “If the symptoms 
persist after specific foods have been eliminated, the assumption can be made that the 
foods avoided are not causing the reaction” (Joneja, 2013, p. 75). There are several 
advantages to the selective elimination diet.  It is relatively quick, easy to diagnose, and 
does not normally adversely affect nutritional status (Joneja, 2013). 
Few foods elimination diet. 
 A few foods elimination diet is useful for reactions in which a specific food 
cannot be identified.  In this case, the diet eliminates most foods except those which are 
thought to be the least likely to trigger an allergic reaction.  Because this diet has negative 
nutritional benefits, it should never be used for more than fourteen days, and extreme 
caution must be used when using this diet in the pediatric population.  Pediatric patients 
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are at high risk for nutritional deficiencies because of their growth rate, and thus 
restricting their nutritional intake may adversely affect their growth and development.  
These patients must be monitored very closely.  Thus, it is not recommended that this diet 
be used before the onset of puberty; normally a selective elimination diet is capable of 
diagnosing food hypersensitivities in the pediatric population.  If it is used for children 
under 7 years old, a period of 7-10 days should not be exceeded.  If symptoms are 
reduced during the duration of the diet, it may be assumed that some type of food protein 
is the cause of the symptoms.  If, however, the symptoms do not respond to the 
elimination, two conclusions may be drawn. The first is that the patient is allergic to one 
of the foods that was not removed.  The second is that the patient’s symptoms are not due 
to food proteins at all.  Further eliminations and challenges may be performed in order to 
distinguish which of the conclusion is accurate (Joneja, 2013). 
 
 
Elemental diet. 
 An elemental diet is used after a selective elimination diet and a few foods 
elimination diet have failed to identify the source of the hypersensitivity reaction and it is 
suspected that the symptoms are the result of multiple food allergies.  This diet is rarely 
used because it is difficult to tolerate.  It is more easily tolerated in infants than in any 
other population.  A nasogastric tube may be used because the elemental formula is not 
appetizing.  All the essential micro and macro nutrients and calories are provided in the 
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form of an amino acid-based formula. This diet must have a physician’s approval and 
should not be continued for a prolonged time period (Joneja, 2013). 
Challenge. 
 Following the elimination diet, the challenge step is begun.  “This is achieved by 
careful challenge with precise quantities of each food component and careful monitoring 
of symptoms development, looking for immediate reactions (within a 4-hour period) or 
delayed reactions (from 1 to 4 days) following ingestion” (Joneja, 2013, p. 85).  There are 
several different methods of conducting a challenge.  The first is a double blind placebo 
controlled food challenge (DBPCFC) and is the gold standard for diagnosis (Venter, et 
al., 2006).  In this challenge, neither the physician nor the patient know which capsule 
contains the suspected food protein and which capsule contains the control substance.  A 
reaction to the suspected food protein is recorded (Joneja, 2013).  A single-blind food 
challenge may be used as well, in which only the patient does not know when he or she is 
receiving the suspected food protein (Joneja, 2013).  The third type of challenge is the 
most common food challenge carried out at home by the patient.  This involves the 
patient controlling when foods are introduced and then noting the subsequent reactions 
(Joneja, 2013).  If the patient demonstrates a hypersensitivity reaction to the foods 
introduced in the challenge, a positive diagnosis of food allergy can be made, and the 
food can be avoided in the future.  If the food does not produce a hypersensitivity 
reaction, then it may be safely reintroduced into the diet (Joneja, 2013). 
Recommendations for Treatment 
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 The best treatment for hypersensitivity reactions that result in anaphylaxis for any 
patient regardless of age is avoidance of the allergen.  It has been shown that children 
may outgrow some of their food allergies, and it is advised that foods may be 
reintroduced to the diet after a specific period of avoidance.  This should usually be about 
one year.  As certain allergens tend to result in life-threatening anaphylaxis and are rarely 
outgrown, it is not recommended that these foods be reintroduced into the diet (Rodgers, 
2017, pp. 330-353).  The most commonly outgrown allergies are milk, eggs, soy and 
wheat.  Allergens like peanuts, tree nuts, fish and shellfish are rarely outgrown especially 
if they result in life-threatening anaphylactoid reactions.  Patients who demonstrated high 
levels of IgE to wheat, milk, and egg are also not likely to develop tolerance and outgrow 
their allergies.  Patients who are likely to outgrow their allergies should be tested after 
every few years of abstinence to see if tolerance has developed.  According to a study 
2013 study,  
For allergy to milk, egg, soy, or wheat, testing every 12-18 months is standard 
practice in the first 5 years of life.  If the food allergy has not resolved by age 5 
years, the interval for follow-up testing is extended to every 2-3 years.  Although 
the likelihood of resolution of peanut allergy is low, resolution occurs most 
commonly by 5 years of age.  Therefore, retesting for peanut allergy could follow 
a similar course as for allergy to milk, egg, soy, or wheat.  Retesting can be done 
every 2-4 years for allergies to tree nuts, fish, and crustacean shellfish (Longo, 
Berti, Burks, Krauss, & Barbi). 
 
 
HYPERSENSITIVITY  23 
 
During the intervals between testing, the allergen should be avoided to prevent recurrence 
of the hypersensitivity reactions.  Because treatments cannot provide assurance of 
complete recovery, diet management and education about avoidance of allergens is 
essential.  This must include planning with a nutritionist and involvement of the family in 
the case of pediatric patients.  If the family is not involved, it is much harder for children 
to eat a healthy diet and completely avoid the allergen.  Thus, healthcare providers must 
be sure to investigate family life and health education to be able to identify resources that 
may best improve the child’s quality of life despite they hypersensitivity reactions 
(Joneja, 2013). 
Oral Immunotherapy 
 Recent research has focused on the use of oral immunotherapy to produce 
desensitization to the allergens.  Further testing is required to prove the efficacy of this 
therapy.  This research found that children who had been diagnosed with egg allergies 
treated with oral immunotherapy showed a lack of hypersensitivity reactions (Longo, 
Berti, Burks, Krauss, & Barbi, 2013).   
Other experts have also called for further research for oral immunotherapy, also 
known as allergen-specific immunotherapy (SIT).  SIT works by regularly exposing the 
patient to the allergens to which they are sensitized.  This is done with the hope that the 
patient might become sensitized over time to the repeated exposure of the allergen.  If 
successful, patients will experience the ability to be exposed to allergens without 
experiencing a hypersensitivity reaction.  Because SIT alters the function of the immune 
system, the positive effects of SIT can be seen long after the treatment has stopped, 
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potentially even life-long.  This occurs because the TH2 response responsible for the 
hypersensitivity reaction has been inhibited by the SIT and the TH1 response that is 
responsible for identifying allergens as safe has been promoted.  SIT also inhibits the 
hypersensitivity reactions through introducing allergen-specific Treg cells.  These Treg 
cells produce IL-10 and TGF-β; these are cytokines that help to produce IgG1, IgG4, and 
IgA antibodies.  These antibodies are called blocking antibodies and they inhibit IgE by 
binding to allergens before IgE.  The third way that SIT inhibits hypersensitivity 
reactions is through modulating the function of APC and effector cells.  This successfully 
decreases the amount of mast cells and thus reduces the mediators released by the mast 
cells.  SIT also successfully reduces the numbers of eosinophils and neutrophils that are 
sent to respond to allergen exposure (Bohle, 2013). 
SIT works differently for Class 1 food allergies and Class 2 food allergies.  In 
class 1 food allergies, SIT is often less successful and may even be dangerous because the 
risk of anaphylactic reactions is very high.  This risk was found to be even higher with 
subcutaneous administration of SIT.  SIT, however, is still being studied in these patients 
to help improve the quality of life for patients.  Recent studies have shown that oral 
administration of SIT and sub-lingual administration of SIT may be safer than 
subcutaneous SIT.  Further research needs to be done as any form of SIT in patients with 
class 1 food allergy carries with it a high risk of anaphylaxis and thus should be 
monitored very closely (Bohle, 2013).  Effective SIT in patients with class 2 food allergy 
often required treatment with both the respiratory allergen and the food allergen.  This is 
because studies found that treatment with the respiratory allergen alone did not reduce 
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hypersensitivity to the associated food allergen.  Likewise, treatment with the food 
allergen alone did not reduce hypersensitivity to the associated respiratory allergen, 
though it was more successful than sole treatment with the respiratory allergen (Bohle, 
2013). 
Recommendations for Healthcare Providers 
 Because hypersensitivity reactions are such a growing health problem, it is 
essential that healthcare providers, especially those working in the pediatric field, be 
familiar with all the aspects of care for hypersensitivity reactions.  This includes how the 
immune system functions, how hypersensitivity reactions occur, how to diagnose food 
hypersensitivities, and how to treat those hypersensitivities.  This could be accomplished 
through continuing education classes and participation in research projects aimed at 
learning more about how the immune system works with regards to hypersensitivity 
reactions. 
Healthcare providers should not only be familiar with how to treat anaphylaxis, 
but also with how to safely administer immunotherapy or SIT.  This will help to improve 
the quality of life of patients with food hypersensitivities and will also increase safety and 
efficacy of treatment.  If more healthcare providers are trained in properly treating 
hypersensitivity reactions, more children will have access to adequate treatment leading 
to better outcomes (Hernandez, Ponce, Busquets, Hernandez, & Oliva, 2016; Bohle, 
2013).   
Because so much research has already been done on how to treat food allergies, 
further research should be done to build on the foundation already built.  There are few 
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treatments available and none are as effective as complete avoidance which is difficult at 
best and often impossible.  Some research is currently being done to develop a vaccine 
for both the prevention and the treatment of hypersensitivity reactions to food.  This 
research is going hand in hand with research in developing safer ways to perform 
immunotherapy treatments (Bohle, 2013). 
Pediatric healthcare providers include any physician, nurse, therapist, or any other 
provider in the healthcare field caring for patients from the neonatal stage through the end 
of adolescence.  Pediatric healthcare providers should also actively participate in 
research.  More research is especially needed in the realms of prevention and treatment 
(Longo, Berti, Burks, Krauss, & Barbi, 2013; Bohle, 2013).  This includes further 
research into breastfeeding and formula feeding and their link to development of 
hypersensitivity reactions; genetic testing for genetic predisposition to hypersensitivity 
reactions, and recommendations for when to begin introducing highly allergenic food into 
the diet (Longo, Berti, Burks, Krauss, & Barbi, 2013).  This also includes further research 
into how to make SIT safer for those with class 1 food allergies, how to make SIT more 
effective for those with class 2 food hypersensitivities, and how a vaccine might be 
developed for prevention and treatment (Bohle, 2013). 
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